Literature DB >> 30860624

Differential ammonia metabolism and toxicity between avian and mammalian species, and effect of ammonia on skeletal muscle: A comparative review.

Rachel A Stern1, Paul E Mozdziak1.   

Abstract

Comparative aspects of ammonia toxicity, specific to liver and skeletal muscle and skeletal muscle metabolism between avian and mammalian species are discussed in the context of models for liver disease and subsequent skeletal muscle wasting. The purpose of this review is to present species differences in ammonia metabolism and to specifically highlight observed differences in skeletal muscle response to excess ammonia in avian species. Ammonia, which is produced during protein catabolism and is an essential component of nucleic acid and protein biosynthesis, is detoxified mainly in the liver. While the liver is consistent as the main organ responsible for ammonia detoxification, there are evolutionary differences in ammonia metabolism and nitrogen excretory products between avian and mammalian species. In patients with liver disease and all mammalian models, inadequate ammonia detoxification and successive increased circulating ammonia concentration, termed hyperammonemia, leads to severe skeletal muscle atrophy, increased apoptosis and reduced protein synthesis, altogether having deleterious effects on muscle size and strength. Previously, an avian embryonic model, designed to determine the effects of increased circulating ammonia on muscle development, revealed that ammonia elicits a positive myogenic response. Specifically, induced hyperammonemia in avian embryos resulted in a reduction in myostatin, a well-known inhibitor of muscle growth, expression, whereas myostatin expression is significantly increased in mammalian models of hyperammonemia. These interesting findings imply that species differences in ammonia metabolism allow avians to utilize ammonia for growth. Understanding the intrinsic physiological mechanisms that allow for ammonia to be utilized for growth has potential to reveal novel approaches to muscle growth in avian species and will provide new targets for preventing muscle degeneration in mammalian species.
© 2019 Blackwell Verlag GmbH.

Entities:  

Keywords:  ammonia; avian; cirrhosis; liver; mammalian; muscle

Mesh:

Substances:

Year:  2019        PMID: 30860624     DOI: 10.1111/jpn.13080

Source DB:  PubMed          Journal:  J Anim Physiol Anim Nutr (Berl)        ISSN: 0931-2439            Impact factor:   2.130


  6 in total

Review 1.  Identifying the shortfalls of crude protein-reduced, wheat-based broiler diets.

Authors:  Peter H Selle; Shemil P Macelline; Shiva Greenhalgh; Peter V Chrystal; Sonia Y Liu
Journal:  Anim Nutr       Date:  2022-08-10

Review 2.  Progress of amino acid nutrition for diet protein reduction in poultry.

Authors:  M T Kidd; C W Maynard; G J Mullenix
Journal:  J Anim Sci Biotechnol       Date:  2021-04-05

3.  In ovo Feeding of L-Leucine Improves Antioxidative Capacity and Spleen Weight and Changes Amino Acid Concentrations in Broilers After Chronic Thermal Stress.

Authors:  Guofeng Han; Yangyang Cui; Dan Shen; Mingyang Li; Yu Ren; Takashi Bungo; Vishwajit S Chowdhury; Yansen Li; Chunmei Li
Journal:  Front Vet Sci       Date:  2022-03-18

Review 4.  A Review of Emerging Goose Astrovirus Causing Gout.

Authors:  Chenggang Liu; Minhua Sun; Ming Liao
Journal:  Biomed Res Int       Date:  2022-08-28       Impact factor: 3.246

5.  Capping dietary starch:protein ratios in moderately reduced crude protein, wheat-based diets showed promise but further reductions generated inferior growth performance in broiler chickens.

Authors:  Shiva Greenhalgh; Bernard V McInerney; Leon R McQuade; Peter V Chrystal; Ali Khoddami; Molly A M Zhuang; Sonia Y Liu; Peter H Selle
Journal:  Anim Nutr       Date:  2020-01-23

Review 6.  Synthetic and Crystalline Amino Acids: Alternatives to Soybean Meal in Chicken-Meat Production.

Authors:  Peter H Selle; Juliano Cesar de Paula Dorigam; Andreas Lemme; Peter V Chrystal; Sonia Y Liu
Journal:  Animals (Basel)       Date:  2020-04-22       Impact factor: 2.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.